MeghanRoseFlanaganMD MPH

PubMed

• 34 citations
  NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
  Therese B Bevers, Bethany L Niell, Jennifer L Baker, Debbie L Bennett, Ermelinda Bonaccio
  Journal of the National Comprehensive Cancer Network. 2023-09-01
• 14 citations
  Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
  Diana L Lam, Meghan R Flanagan
  JAMA. 2022-01-11
• 32 citations
  Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor
  Meghan R. Flanagan, Emily C. Zabor, Michelle Stempel, Debra A. Mangino, Monica Morrow
  Annals of Surgical Oncology. 2019-02-27

Journal Articles

• Effects of Gender Bias and Stereotypes in Surgical Training  
  Mohini Dasari, Matthew D Neal, Stephanie M Downs-Canner, Meghan R Flanagan, Kenneth K Lee, Matthew R Rosengart, JAMA Surgery
• Relationship between anthropomorphic factors and risk of second breast cancer among women with a history of ductal carcinoma in situ  
  Flanagan MR, Tang MC, Baglia ML, Porter PL, Malone KE, Li CI., JNCI Cancer Spectrum, 1/1/2018
• Positron emission tomography for initial staging of esophageal cancer among medicare beneficiaries  
  Simianu VV, Varghese TK, Flanagan MR, Flum DR, Shankaran V, Oelschlager BK, Mulligan MS, Wood DE, Pellegrini CA, Farjah FF, J Gastrointest Oncol, 1/1/2016
• Primary cesarean section and adverse delivery outcomes among women of very advanced maternal age  
  Richards MR and Flanagan MR*, Littman AJ, Burke AK, Callegari LS., J Perinatol., 1/1/2016
• Aligning institutional priorities: engaging house staff in a quality improvement and safety initiative to fulfill Clinical Learning Environment Review objectives and e...  
  Flanagan MR and Foster CC*, Schleyer A, Peterson GN, Mandell SP, Rudd KE, Joyner BD, Payne TH, Am J Surg., 1/1/2016
• Gaps in guideline concordant use of diagnostic tests among lung cancer patients  
  Flanagan MR, Varghese TK, Backhus LM, Wood DE, Mulligan MS, Cheng AM, Flum DR, Farjah FF., Ann Thorac Surg., 1/1/2015
• Pleomorphic lobular carcinoma in situ: radiologic�pathologic features and clinical management  
  Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH., Ann Surg Oncol., 1/1/2015
• Adjuvant endocrine therapy in patients with ductal carcinoma in situ: a population-based retrospective analysis from 2005 to 2012 in the National Cancer Database  
  Flanagan MR, Rendi MH, Gadi VK, Calhoun KE, Gow KW, Javid SH., Ann Surg Oncol, 1/1/2015
• Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch Syndrome  
  Flanagan MR, Jayaraj A, Xiong W, Yeh MM, Raskind WH, Pillarisetty VG, World J Gastroenterol, 1/1/2015
• Status of intraductal therapy for ductal carcinoma in situ  
  Flanagan MR, Love S, Hwang ES., Curr Breast Cancer Rep., 1/1/2010
• What to know about breast density and your breast cancer risk  
  Flanagan MR., Right as Rain by UW Medicine., 1/31/2018
• Join now to see all

Books/Book Chapters

• Textbook of Complex General Surgical Oncology. 
  Chapter: Ductal Carcinoma in Situ. 
  Flanagan M, Chen Y, Hwang E.Editors: Morita SY, Balch CM, Klimberg V, Pawlik TM, Posner MC, Tanabe KK..McGraw-Hill.2018
• Atypical Breast Proliferative Lesions and Benign Breast Disease 
  Chapter: Surgical treatment of ductal carcinoma in situ. 
  Flanagan MR, Van Zee KJ.Editors: Amersi F, Calhoun K..Springer, Cham2018
• Atypical Breast Proliferative Lesions and Benign Breast Disease 
  Chapter: Lobular carcinoma in situ natural history: risk factor lesion or cancer precursor? 
  Sullivan KM, Flanagan MR, Kilgore MR, Anderson BOEditors: Amersi F, Calhoun K..Springer, Cham2018

Abstracts/Posters

• At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required?
  Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HC, J Clin Oncol, 1/1/2018
• Chemoprevention uptake for breast cancer risk reduction varies by risk factor.
  Flanagan MR, Zabor EC, Stempel M, Mangino DA, Morrow M, Pilewskie ML., Ann Surg Oncol, 1/1/2018
• Is Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer Cost-Effective?
  Schwartz NRM, Flanagan MR, Babigumira JB, Steuten LM, Roth JA, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2018
• At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required?
  Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HC, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2018
• Comparative trends in hormone replacement therapy and breast cancer incidence in the United States: does hormone replacement therapy explain declining breast cancer ra...
  Verdial FC, Flanagan MR, Anderson BO., J Am Coll Surg, 1/1/2017
• A multidisciplinary checklist and structured handover reporting format improves post-operative information transfer.
  Shah AC, Herstein AR, Flanagan MR, Flynn-O�Brien KT, Oh D, Xue A, American Society of Anesthesiologists Annual Meeting, Boston, MA, 1/1/2017
• Adverse outcomes and quality of life associated with immediate breast reconstruction after mastectomy in Washington state, 2011-2013.
  Flanagan MR, Lavallee A, Colohan SM, Flum DR, Javid SH, J Am Coll Surg, 1/1/2015
• Adverse Outcomes and Quality of Life Associated with Immediate Breast Reconstruction After Mastectomy in Washington State, 2011-2013.
  Flanagan MR, et al., American College of Surgeons Clinical Congress, Chicago, IL, 1/1/2015
• Aligning Institutional Priorities: Engaging Housestaff in Quality Improvement and Safety Initiatives to Fulfill CLER Guidelines and Meaningful Use.
  Flanagan MR, et al., Association for Surgical Education Annual Meeting, Seattle, WA, 1/1/2015
• Process-of-care utilization in lung cancer surgery.
  Flanagan MR, Varghese TK, Backhus LM, Wood DE, Mulligan MS, Cheng AM, Alfonso-Cristancho R, Flum DR, Farjah FF., J Am Coll Surg, 1/1/2014
• Management of Patients with Biopsy Diagnosis of Isolated Pleomorphic Lobular Carcincoma in Situ
  Flanagan MR, et al., North Pacific Surgical Association Annual Meeting, Seattle, WA, 1/1/2014
• Building a Successful and Productive Housestaff Quality and Safety Council.
  Schook CC and Flanagan MR, et al., Accreditation Council for Graduate Medical Education Annual Meeting, Washington, DC, 1/1/2014
• Join now to see all

Lectures

• A Comparison of Patient-Reported Outcomes after Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction 
  Dallas, TX - 1/1/2019
• At surgery for a core needle biopsy diagnosis of ductal carcinoma in situ with microinvasion: Is sentinel lymph node biopsy required? 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Evolution of the surgical management of breast cancer. 
  Seattle, WA - 1/1/2018
• Ductal carcinoma in situ: risk factor lesion or cancer 
  Boston, MA - 1/1/2018
• Chemoprevention uptake for breast cancer risk reduction varies by risk factor. 
  Chicago, IL - 1/1/2018
• Adverse Outcomes and Quality of Life Associated with Immediate Breast Reconstruction After Mastectomy in Washington State, 2011-2013. 
  Suncadia, WA - 1/1/2015
• Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma in Situ in the National Cancer Database. 
  Orlando, FL - 1/1/2015
• Process-of-Care Utilization in Lung Cancer Surgery 
  Bend, OR, 2014; San Francisco, CA, 2014 - 1/1/2014
• Join now to see all

Other

• Comparative trends in hormone replacement therapy and breast cancer incidence in the United States: does hormone replacement therapy explain declining breast cancer ra... 
  Verdial FC, Flanagan MR, Anderson BO., American College of Surgeons Annual Meeting
  San Diego, CA - 1/1/2017
• Adverse Outcomes and Quality of Life Associated with Immediate Breast Reconstruction After Mastectomy in Washington State, 2011-2013. 
  Flanagan MR, et al.
  http://goo.gl/ZFMxTC
  Chicago, IL - 1/1/2015